Microscopic polyangiitis: Difference between revisions

	Microscopic polyangiitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Microscopic polyangiitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Radiation therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Microscopic polyangiitis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Microscopic polyangiitis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Microscopic polyangiitis
CDC on Microscopic polyangiitis
Microscopic polyangiitis in the news
Blogs on Microscopic polyangiitis
Directions to Hospitals Treating Type chapter name here
Risk calculators and risk factors for Microscopic polyangiitis

VisualWikitext

Latest revision as of 12:59, 23 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]Vindhya BellamKonda, M.B.B.S [3]

Synonyms and keywords: MPA

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Any Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Template:WH Template:WS

References

Related Chapters

Template:Diseases of the musculoskeletal system and connective tissue de:Mikroskopische Polyangiitis nl:Microscopische polyangiitis

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Infobox_Disease |
+{{Microscopic polyangiitis}}
-  Name           = {{PAGENAME}} |
-  Image          = |
+{{CMG}} ; {{AE}} {{VKG}}{{Vbe}}
-  Caption        = |
-  DiseasesDB     = 8193 |
-  ICD10          = {{ICD10|M|31|7|m|30}} |
-  ICD9           = |
-  ICDO           = |
-  OMIM           = |
-  MedlinePlus    = |
-  MeshID         = |
-}}
-{{SI}}
-{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
 {{SK}} MPA
-==Overview==
-'''Microscopic polyangiitis (MPA) ''' is an ill-defined [[autoimmune disease]] characterized by pauci-immune, necrotizing, small-vessel [[vasculitis]] without clinical or pathological evidence of necrotizing granulomatous [[inflammation]]. Because many different organ systems may be involved, a wide range of symptoms are possible in MPA.
+==[[Microscopic polyangiitis overview|Overview]]==
-==Cause==
-This condition, the clinical picture of which may include many features of systemic lupus erythematosis, has been reported to have been caused by [[antibiotics]] and also by certain [[infection]]s, though, as with many autoimmune diseases, the causes remain to a large extent unknown.
+==[[Microscopic polyangiitis historical perspective|Historical Perspective]]==
+==[[Microscopic polyangiitis classification|Classification]]==
+==[[Microscopic polyangiitis pathophysiology|Pathophysiology]]==
+==[[Microscopic polyangiitis causes|Causes]]==
+==[[Microscopic polyangiitis differential diagnosis|Differentiating Any Disease from other Diseases]]==
+==[[Microscopic polyangiitis epidemiology and demographics|Epidemiology and Demographics]]==
+==[[Microscopic polyangiitis risk factors|Risk Factors]]==
+==[[Microscopic polyangiitis screening|Screening]]==
+==[[Microscopic polyangiitis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 ==Diagnosis==
-Laboratory tests show an increased sedimentation rate, reduced red blood count, antineutrophil cytoplasmic antibodies (p-ANCA) directed against [MPO(a constituent of [[neutrophil]] granules), and [[protein]] and red blood cells in the [[urine]].
+[[Microscopic polyangiitis history and symptoms|History and Symptoms]] | [[Microscopic polyangiitis physical examination|Physical Examination]] | [[Microscopic polyangiitis laboratory findings|Laboratory Findings]] | [[Microscopic polyangiitis electrocardiogram|Electrocardiogram]] | [[Microscopic polyangiitis chest x ray|Chest X Ray]] | [[Microscopic polyangiitis CT|CT]] | [[Microscopic polyangiitis MRI|MRI]] | [[Microscopic polyangiitis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Microscopic polyangiitis other imaging findings|Other Imaging Findings]] | [[Microscopic polyangiitis other diagnostic studies|Other Diagnostic Studies]]
-The test for [[anti-glomerular basement membrane antibody]] (GBM), which is positive in [[Goodpasture's syndrome]], is negative.
 ==Treatment==
-The customary treatment involves long term dosage of [[prednisone]], alternated or combined with [[cytotoxic]] drugs, such as [[cyclophosphamide]] or [[azathioprine]]. [[Plasmapheresis]] may also be indicated in the acute setting to remove ANCA antibodies.
+[[Microscopic polyangiitis medical therapy|Medical Therapy]] | [[Microscopic polyangiitis surgery|Surgery]] | [[Microscopic polyangiitis primary prevention|Primary Prevention]] | [[Microscopic polyangiitis secondary prevention|Secondary Prevention]] | [[Microscopic polyangiitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Microscopic polyangiitis future or investigational therapies|Future or Investigational Therapies]]
+==Case Studies==
+[[Microscopic polyangiitis case study one|Case #1]]
+[[Category:Projects]]
+[[Category:Help]]
+{{WH}}
+{{WS}}
+==References==
+{{reflist|2}}
 ==Related Chapters==
 * [[ANCA-associated vasculitides]]
-*[[Polyarteritis nodosa]]
+* [[Polyarteritis nodosa]]
 {{Diseases of the musculoskeletal system and connective tissue}}

Microscopic polyangiitis: Difference between revisions

Latest revision as of 12:59, 23 July 2018

Diagnosis

Treatment

Case Studies

References

Related Chapters

Navigation menu